Liberation Labs Announces Manufacturing Partnership with Vivici

RICHMOND, Ind., May 07, 2025 (GLOBE NEWSWIRE) -- Liberation Labs today announced a manufacturing partnership with Dutch ingredients startup Vivici. Liberation Labs will produce Vivici’s flagship ingredient, Vivitein™ BLG, at its Richmond, Indiana facility when commercial production begins in 2026.

The New Standard of Protein, Vivitein™ BLG is a dairy protein (beta-lactoglobulin) produced through precision fermentation enabling B2B customers to launch disruptive, differentiated and better overall products to consumers in the US market. These include clear water-based protein drinks with innovative flavors, clean protein powders with superior muscle-building performance and rapid absorption and vegan-friendly protein bars with luscious chewy textures.

“Vivici is a perfect reference case for our facility - a company seeking cost-effective and sustainable manufacturing of a novel protein ingredient that unlocks a range of other healthy and innovative products,” said Mark Warner, founder and CEO of Liberation Labs. “We love what Vivici is doing and will be proud to play a role in their success.”

Liberation Labs is in the late stages of constructing its first commercial-scale, purpose-built, precision fermentation biomanufacturing facility with a capacity of 600,000 liters and a fully dedicated downstream process (DSP). The plant will produce a range of bio-based materials, including building block ingredients for food, chemicals and other industrial products at a scale and cost that will fill a pressing need among both new and established consumer packaged goods (CPG) companies and other industrial manufacturers.

“As awareness of the important role protein plays in supporting active lifestyles continues to grow, American consumers are demanding higher quality and greater quantities of protein in their diets.” said Stephan van Sint Fiet, CEO of Vivici. “Our partnership with Liberation Labs expands our European manufacturing capabilities, providing US customers with increased supply security for Vivitein™ BLG.”

About Liberation Labs
Liberation Labs is commercializing precision fermentation with a global network of purpose-built manufacturing facilities that enable the next wave of biotechnology advancements to produce bio-based consumer products at scale. We combine modern technology with fit-for-purpose design to bring reliable and cost-effective solutions that meet customer demand across the world. Our flagship facility in Richmond, Indiana is expected to begin production in 2026 and we have begun a feasibility study for a second plant in Saudi Arabia. More information is available at www.liberationlabs.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/dc296fed-1bdf-485d-a083-0efd5192faa2

Media Contact
John Williams, Scoville PR for Liberation Labs
+1-206-660-5503, [email protected]

Liberation Labs Announces Manufacturing Partnership with Vivici

Liberation Labs will produce Vivici’s flagship ingredient, Vivitein BLG (a dairy protein) at its Richmond, Indiana facility when commercial production begins in 2026.

You May Also Be Interested In

• Futu Holdings Limited Securities Fraud Class Action Result of Undisclosed Regulatory Compliance Failures and approximately 32% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Fo
• PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and approximately 18% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti,
• PINSPARK Celebrates National Golf Month with High-Performance UPF 50+ Golf Collection – Summer Style on the Course for Men and Women